» Articles » PMID: 25476661

Diagnostic Accuracy of Plasma Free Metanephrines in a Seated Position Compared with 24-hour Urinary Metanephrines in the Investigation of Pheochromocytoma

Overview
Journal Endocr J
Specialty Endocrinology
Date 2014 Dec 6
PMID 25476661
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to determine the diagnostic efficacy of free metanephrines in plasma samples drawn in the seated position compared with 24-h urinary metanephrines in detecting pheochromocytomas in Asian patients. This prospective study was conducted at Samsung Medical Center between May 2010 and July 2011. The study contained 245 subjects, including 28 patients with histologically-proven pheochromocytoma, 44 with histologically-proven non-pheochromocytoma, 112 controls suspected of having tumors but with negative investigations during two or more years of follow-up, and 45 healthy normotensive volunteers. Plasma-free metanephrines were measured by LC-MS/MS. The cut-off values with optimal sensitivity and specificity for plasma metanephrine and plasma normetanephrine were 0.33 nmol/L and 0.61 nmol/L, respectively. Both the plasma metanephrines measurement and urinary metanephrines measurement had a sensitivity of 96.4% (p = 1.00). However, the urinary metanephrines measurement was significantly more specific than the plasma metanephrines measurement (94.2% vs. 75.6%; p < 0.001). When we applied cut-off values based on BMI, specificity improved from 75.6% to 87.2%, with a comparable gain in sensitivity. From a diagnostic perspective, measurement of free metanephrines in plasma drawn in the seated position is highly sensitive but insufficiently specific when compared with measurement of 24-h urinary fractionated metanephrines. The specificity may be improved by applying cut-off values based on BMI. We suggest that free metanephrines in plasma drawn from seated position can also be used as an initial screening test to ensure that pheochromocytomas are not missed in Asian patients.

Citing Articles

Analysis of Urinary Metanephrines Using Liquid Chromatography Tandem Mass Spectrometry.

Thaitumu M, Frank E Methods Mol Biol. 2025; 2891():257-268.

PMID: 39812987 DOI: 10.1007/978-1-0716-4334-1_14.


Pheochromocytoma: an updated scoping review from clinical presentation to management and treatment.

Saavedra T J, Nati-Castillo H, Valderrama Cometa L, Rivera-Martinez W, Asprilla J, Castano-Giraldo C Front Endocrinol (Lausanne). 2024; 15:1433582.

PMID: 39735644 PMC: 11671257. DOI: 10.3389/fendo.2024.1433582.


Perioperative management of patients with glioblastoma copresenting with pheochromocytoma: illustrative case.

Guo E, Keough M, Henderson A, Hagen E, Levine M, Arnason T J Neurosurg Case Lessons. 2024; 8(21).

PMID: 39556820 PMC: 11579913. DOI: 10.3171/CASE24374.


A rare case of pheochromocytoma in a pregnant woman presenting with chest pain: extraordinary management.

Ge T, Xie X, Liu J BMC Cardiovasc Disord. 2024; 24(1):261.

PMID: 38769478 PMC: 11103813. DOI: 10.1186/s12872-024-03943-7.


Development and validation of a simple, fast and sensitive liquid chromatography-tandem mass spectrometry method to establish reference intervals for 24-h urinary free normetanephrine, metanephrine and methoxytyramine.

Song Y, Xu R, Liu D, Zhang J Pract Lab Med. 2024; 39:e00358.

PMID: 38318432 PMC: 10840320. DOI: 10.1016/j.plabm.2024.e00358.